Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective.
Pulmonary hypertension (PH) affects > 25 million individuals worldwide and causes premature disability and death for many. The diagnosis and treatment of PH have advanced dramatically through the development of a clearly defined diagnostic classification, an evidence-based treatment algorithm for adults with pulmonary arterial hypertension using life-saving medications, and life-saving surgical procedures. However, worldwide education and training of physicians has lagged behind advances in the management of PH. Expertise in the diagnosis and management of PH is uncommon, even though physicians receive training on PH during their graduate and postgraduate education. Advances in worldwide physician education and training in PH will require substantial organization and work. Organizations working in this field will need to work collaboratively to maximize funding for education and to optimize the achievement of educational goals. Political, economic, and cultural barriers must be identified and overcome as part of any strategic plan. Global education should include training objectives for generalist, non-PH specialist, and PH specialist physicians.
Elliott
C Gregory
CG
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT 84157-7000, USA. greg.elliott@imail.org
Barst
Robyn J
RJ
Seeger
Werner
W
Porres-Aguilar
Mateo
M
Brown
Lynette M
LM
Zamanian
Roham T
RT
Rubin
Lewis J
LJ
D002983:Clinical Competence; D004502:Education, Medical, Continuing; D014943:Global Health; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D017145:Models, Educational